Advertisement
Advertisement

GOVX

GOVX logo

Geovax Labs Inc

2.27
USD
+0.055
+2.49%
Dec 24, 12:59 UTC -5
Closed
...

Geovax Labs Inc Profile

About

GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.

Info & Links

CEO

David A. Dodd

Headquarters

1900 LAKE PARK DRIVE, SUITE 380
SMYRNA, GA 30080, UNITED STATES

Auditor

WIPFLI LLP

Share holders

14

Employees

17

Geovax Labs Inc Statistics

Valuation Measures

Market Capitalization2

21.38M

Enterprise Value

12.79M

Enterprise Value/EBITDA(ttm)

-0.52

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.26

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-473.17%

Return on Equity(ttm)

-809.87%

Return on Invested Capital(ttm)

-10759.52%

Return on Assets(ttm)

-349.34%

Income Statement

Revenue(ttm)

3.09M

Revenue Per Share(ttm)

0.33

Gross Profit(ttm)

3.09M

EBITDA(ttm)3

-24.40M

Net Income Available to Common(ttm)

-24.32M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

3.24

52-Week Change

-62.37%

S&P 500 52-Week Change

26.50%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

9.44M

Dividend Yield

0.00%

Float4

8.90M

% Held by Insiders

5.70%

% Held by Institutions

6.09%

Balance Sheet

Total Cash(mrq)

8.59M

Total Cash Per Share(mrq)

0.91

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.17%

Quick Ratio(mrq)

4.17%

Book Value Per Share(mrq)

0.99

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.64

Free Cash Flow(ytd)

-16.94M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement